Notifiable diseases, United States, 1994

"This publication contains summary tables of the official statistics for the reported occurrence of nationally notifiable diseases in the United States for the year 1994. This information is collected and compiled from reports to the National Notifiable Diseases Surveillance System (NNDSS). Because the dates of onset and dates of diagnosis for notifiable diseases are often unknown, these surveillance data are presented by the week that they were reported to public health officials. These data are then finalized and published in the MMWR Summary of Notifiable Diseases, United States, for use by state and local health departments; schools of medicine and public health; communications media; local, state, and federal agencies; and other agencies or persons interested in following the trends of reportable conditions in the United States. Publication of the annual summary also ensures documentation of diseases that are considered national priorities for notification and of the annual number of cases of such diseases. Part 1 contains information on morbidity for each of the conditions considered nationally notifiable during 1994. In all tables, leprosy is listed as Hansen disease and typhus fever (tick-borne) as Rocky Mountain spotted fever (RMSF). The tables show the number of cases of notifiable diseases reported to CDC for 1994, as well as the distribution of cases by month and geographic location, and by patient's age, race, and ethnicity. The data are final totals as of July 7, 1995, unless otherwise noted. Part 2 contains graphs and maps depicting summary data for many of the notifiable conditions described in tabular form in Part I. Part 3 includes tables showing the number of cases of notifiable diseases reported to CDC and to the National Office of Vital Statistics since 1945. It also includes a table on deaths associated with specified notifiable diseases reported to the National Center for Health Statistics, CDC, for the period 1983-1992." - p. iiForeward -- Background -- Data sources -- Interpreting data -- 1994 Highlights for selected diseases -- Bibliography -- Summaries of notifiable diseases in the United States, 1994 -- Graphs and maps for selected notifiable diseases in the United States -- Historical summary tables covering the period 1945-1994 -- Notifiable DiseasesThe following CDC staff members contributed to this report: Denise T. Koo, Andrew G. Dean, Ruth W. Slade, Carol M. Knowles, Deborah A. Adams, Wanda K. Fortune, Patsy A. Hall, Robert F. Fagan, Barbara Panter-Connah, Harry R. Holden, Gerald F. Jones, Clarence Lee Maddox, Division of Surveillance and Epidemiology, Epidemiology Program Office; Dana J. Milk, Scientific Information and Communications Program, Public Health Publications Branch, Epidemiology Program Office; Consultant: , Willie J. Anderson, , Office of the Vice President for Health Affairs, Emory University.Bibliography: p. x-xvi.756553

Statistical summary of notifiable diseases in the United States

"This publication contains summary tables of the official statistics for the occurrence of nationally notifiable diseases in the United States for calendar year 1993. This information is collected and compiled from reports to the National Notifiable Diseases Surveillance System (NNDSS). Part 1 contains information on morbidity for each of the 49 currently notifiable conditions. In all tables, leprosy is listed as Hansen disease, typhus fever (flea-borne) as murine typhus fever, and typhus fever (tick-borne) as Rocky Mountain spotted fever (RMSF). The tables show the number of cases of notifiable diseases reported to CDC for 1993, as well as the distribution of cases by month and geographic location, and by patient's age, race, and ethnicity. Part 2 contains graphs and maps depicting summary data for many of the notifiable conditions described in tabular form in Part I. Part 3 includes tables showing the number of cases of notifiable diseases reported to CDC and to the National Office of Vital Statistics since 1944. It also includes a table on deaths associated with specified notifiable diseases reported to the National Center for Health Statistics, CDC, for the period 1982-1991." - p. iiForeward -- Background -- Data sources -- Interpreting data -- 1993 Highlights for selected diseases -- Selected bibliography -- Summaries of notifiable diseases in the United States, 1993 -- Graphs and maps for selected notifiable diseases in the United States -- Historical summary tables covering the period 1944-199 -- Notifiable Diseases"The following CDC staff members prepared this report: Denise T. Koo, Andrew G. Dean, Ruth W. Slade, Carol M. Knowles, Deborah A. Adams, Wanda K. Fortune, Patsy A. Hall, Robert F. Fagan, Barbara Panter-Connah, Harry R. Holden, Gerald F. Jones, Clarence Lee Maddox, Division of Surveillance and Epidemiology, Epidemiology Program Office; Consultant: Willie J. Anderson, Office of the Vice President for Health Affairs, Emory University.""The statistical summary of notifiable diseases in the United States is published to accompany each volume of the Morbidity and mortality weekly report."--T.p. verso.Bibliography: p. xi-xvii.924736

Public Health and Epidemiology Informatics: Recent Research Trends

OBJECTIVES: To introduce and analyse current trends in Public Health and Epidemiology Informatics. METHODS: PubMed search of 2020 literature on public health and epidemiology informatics was conducted and all retrieved references were reviewed by the two section editors. Then, 15 candidate best papers were selected among the 920 references. These papers were then peer-reviewed by the two section editors, two chief editors, and external reviewers, including at least two senior faculty, to allow the Editorial Committee of the 2021 International Medical Informatics Association (IMIA) Yearbook to make an informed decision regarding the selection of the best papers. RESULTS: Among the 920 references retrieved from PubMed, four were suggested as best papers and the first three were finally selected. The fourth paper was excluded because of reproducibility issues. The first best paper is a very public health focused paper with health informatics and biostatistics methods applied to stratify patients within a cohort in order to identify those at risk of suicide; the second paper describes the use of a randomized design to test the likely impact of fear-based messages, with and without empowering self-management elements, on patient consultations or antibiotic requests for influenza-like illnesses. The third selected paper evaluates the perception among communities of routine use of Whole Genome Sequencing and Big Data technologies to capture more detailed and specific personal information. CONCLUSIONS: The findings from the three studies suggest that using Public Health and Epidemiology Informatics methods could leverage, when combined with Deep Learning, early interventions and appropriate treatments to mitigate suicide risk. Further, they also demonstrate that well informing and empowering patients could help them to be involved more in their care process

Framework for evaluating public health surveillance systems for early detection of outbreaks: recommendations from the CDC Working Group

"The threat of terrorism and high-profile disease outbreaks has drawn attention to public health surveillance systems for early detection of outbreaks. State and local health departments are enhancing existing surveillance systems and developing new systems to better detect outbreaks through public health surveillance. However, information is limited about the usefulness of surveillance systems for outbreak detection or the best ways to support this function. This report supplements previous guidelines for evaluating public health surveillance systems. Use of this framework is intended to improve decision-making regarding the implementation of surveillance for outbreak detection. Use of a standardized evaluation methodology, including description of system design and operation, also will enhance the exchange of information regarding methods to improve early detection of outbreaks. The framework directs particular attention to the measurement of timeliness and validity for outbreak detection. The evaluation framework is designed to support assessment and description of all surveillance approaches to early detection, whether through traditional disease reporting, specialized analytic routines for aberration detection, or surveillance using early indicators of disease outbreaks, such as syndromic surveillance." - p. 1prepared by James W. Buehler, Richard S. Hopkins, J. Marc Overhage, Daniel M. Sosin, Van Tong.Cover title."May 7, 2004.""The material in this report originated in the Epidemiology Program Office, Stephen B. Thacker, M.D., Director, and the Division of Public Health Surveillance and Informatics, Daniel M. Sosin, M.D., Director."Includes bibliographical references (p. 10-11)

Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation

Recent advances in genomic research have demonstrated a substantial role for genomic factors in predicting response to cancer therapies. Researchers in the fields of cancer pharmacogenomics and pharmacoepidemiology seek to understand why individuals respond differently to drug therapy, in terms of both adverse effects and treatment efficacy. To identify research priorities as well as the resources and infrastructure needed to advance these fields, the National Cancer Institute (NCI) sponsored a workshop titled “Cancer Pharmacogenomics: Setting a Research Agenda to Accelerate Translation” on July 21, 2009, in Bethesda, MD. In this commentary, we summarize and discuss five science-based recommendations and four infrastructure-based recommendations that were identified as a result of discussions held during this workshop. Key recommendations include 1) supporting the routine collection of germline and tumor biospecimens in NCI-sponsored clinical trials and in some observational and population-based studies; 2) incorporating pharmacogenomic markers into clinical trials; 3) addressing the ethical, legal, social, and biospecimen- and data-sharing implications of pharmacogenomic and pharmacoepidemiologic research; and 4) establishing partnerships across NCI, with other federal agencies, and with industry. Together, these recommendations will facilitate the discovery and validation of clinical, sociodemographic, lifestyle, and genomic markers related to cancer treatment response and adverse events, and they will improve both the speed and efficiency by which new pharmacogenomic and pharmacoepidemiologic information is translated into clinical practice

Summary of notifiable diseases -- United States, 1999

"The MMWR Summary of Notifiable Diseases, United States, 1999 contains, in tabular and graphical form, the official statistics for the reported occurrence of nationally notifiable diseases in the United States for 1999. These statistics are collected and compiled from reports to the National Notifiable Diseases Surveillance System (NNDSS), which is operated by CDC in collaboration with the Council of State and Territorial Epidemiologists (CSTE). The Summary is located on the Internet at . This site also includes publications from past years. Because the dates of onset or diagnosis for notifiable diseases are not always reported, these surveillance data are presented by the week they were reported to CDC by public health officials in state and territorial health departments. These data are finalized and published each year in the Summary for use by state and local health departments; schools of medicine and public health; communications media; local, state, and federal agencies; and other agencies or persons interested in following the trends of reportable diseases in the United States. This publication also documents which diseases are considered national priorities for notification and the annual number of cases of such diseases. The Highlights section presents information on selected nationally notifiable diseases to provide a context in which to interpret surveillance and disease-trend data and to provide further information on the epidemiology and prevention of selected diseases. Past publications included information on selected non-notifiable diseases, but this year's Summary presents only highlights of nationally notifiable diseases. Part 1 contains tables that present incidence data for each of the diseases considered nationally notifiable during 1999. The tables provide the number of cases of notifiable diseases reported to CDC for 1999, as well as the distribution of cases by month and geographic location and by patient's age, sex, race, and Hispanic ethnicity. The data are final totals as of August 15, 2000, unless otherwise noted. In all tables, leprosy is listed as Hansen disease, and tickborne typhus fever is listed as Rocky Mountain spotted fever (RMSF). Part 2 contains graphs and maps. These graphs and maps depict summary data for many of the notifiable diseases described in tabular form in Part 1. Part 3 contains tables that list the number of cases of notifiable diseases reported to CDC since 1968. This section also includes a table enumerating deaths associated with specified notifiable diseases reported to the National Center for Health Statistics (NCHS), CDC, during 1989-1998. The Selected Reading section presents general and disease-specific references for notifiable infectious diseases. These references provide additional information on surveillance and epidemiologic issues, diagnostic issues, or disease control activities." - p. ivPreface -- Background -- Data sources -- Interpreting data -- Highlights -- Summaries of notifiable diseases in the United States, 1999 -- Graphs and maps for selected notifiable diseases in the United States -- Historical summaries of notifiable diseases in the United States, 1968--1999 -- Selected readingThe following CDC staff members contributed to this report: Samuel L. Groseclose, Patsy A. Hall, Carol M. Knowles, Deborah A. Adams, Suzette Park, Felicia Perry, Pearl Sharp, Willie J. Anderson, Kathryn Snavely, Robert F. Fagan, J. Javier Aponte, Gerald F. Jones, David A. Nitschke, Carol A. Worsham, M. Kathleen Glynn, ManHuei Chang,. Timothy Doyle, Ruth Ann Jajosky, Division of Public Health Surveillance and Informatics, Epidemiology Program Office; in collaboration with Scott Noldy, EDS Corp.Selected reading: p. 91-101

Notifiable diseases, United States, 1995

Foreward -- Background -- Data sources -- Interpreting data -- 1995 Highlights for selected diseases -- Summaries of notifiable diseases in the United States, 1995 -- Graphs and maps for selected notifiable diseases in the United States -- Historical summary tables covering the period 1966-1995 -- Bibliography"The following CDC staff members contributed to this report: Denise T. Koo, Andrew G. Dean, Myra A. Montalbano, Carol M. Knowles, Deborah A. Adams, Timothy M. Copeland, Patsy A. Hall, Robert F. Fagan, Harry R. Holden, Gerald F. Jones, Clarence Lee Maddox, Division of Surveillance and Epidemiology, Epidemiology Program Office; Consultant: Willie J. Anderson, Office of the Vice President for Health Affairs, Emory University."Bibliography: p. 81-87.892699

Notifiable diseases, United States, 1997

"This publication contains summary tables of the official statistics for the reported occurrence of nationally notifiable diseases in the United States for 1997. These statistics are collected and compiled from reports to the National Notifiable Diseases Surveillance System (NNDSS), which is operated by CDC in collaboration with the Council of State and Territorial Epidemiologists (CSTE). Because the dates of onset or diagnosis for notifiable diseases are not always reported, these surveillance data are presented by the week they were reported to CDC by public health officials in state and territorial health departments. These data are finalized and published in the MMWR Summary of Notifiable Diseases, United States for use by state and local health departments; schools of medicine and public health; communications media; local, state, and federal agencies; and other agencies or persons interested in following the trends of reportable diseases in the United States. The annual publication of the Summary also documents which diseases are considered national priorities for notification and the annual number of cases of such diseases. The Highlights section presents information on selected nationally notifiable and non-notifiable diseases to provide a context in which to interpret surveillance and disease-trend data and to provide further information on the epidemiology and prevention of selected diseases. Part 1 contains information regarding morbidity for each of the diseases considered nationally notifiable during 1997. The tables provide the number of cases of notifiable diseases reported to CDC for 1997, as well as the distribution of cases by month and geographic location and by patient's age, sex, race, and Hispanic ethnicity. The data are final totals as of July 25, 1998, unless otherwise noted. Because no cases of anthrax or yellow fever were reported in the United States during 1997, these nationally notifiable diseases do not appear in the tables in Part 1. Nationally notifiable diseases that are reportable in fewer than 40 states also do not appear in these tables. In all tables, leprosy is listed as Hansen disease, and tickborne typhus fever is listed as Rocky Mountain spotted fever (RMSF). Part 2 contains graphs and maps. These graphs and maps depict summary data for many of the notifiable diseases described in tabular form in Part 1. Part 3 contains tables that list the number of cases of notifiable diseases reported to CDC since 1966. It also includes a table enumerating deaths associated with specified notifiable diseases reported to the National Center for Health Statistics, CDC during 1987-1996." - p. 1Summaries of notifiable diseases in the United States, 1997 -- Graphs and maps for selected notifiable diseases in the United States -- Historical summary tables covering the period 1966-1997 -- BibliographyThe following CDC staff members contributed to this report: Samuel L. Groseclose, Myra A. Montalbano, Carol M. Knowles, Deborah A. Adams, Patsy A. Hall, Robert F. Fagan, Karl A. Brendel, Harry R. Holden, Gerald F. Jones, Division of Public Health Surveillance and Informatics, Epidemiology Program Office; in collaboration with Willie J. Anderson, Rollins School of Public Health. Emory University; Angela Trosclair, Carol A. Worsham, TRW, Inc.Bibliography: p. 81-87.1007537